Publications by authors named "Mahak Arora"

Claim this Profile
R
Regulation of inflammatory pathways by cannabigerol in the collagen induced arthritis model in rats.
Monika Šteigerová, Michaela Sklenárová, Mykhaylo Bazyuk, Luděk Záveský, Petr Jelínek, Mahak Arora

Front Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of the SREBP1/2 inhibitor, fatostatin, in a preclinical model of metabolic dysfunction-associated steatotic liver disease progression.
Mahak Arora, Nikolina Canová, Tijana Šopin, Zuzana Pavlíková, Tomáš Kučera

Eur J Pharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Quantitative Structural Properties and Drug Formulation in Four Cannabinoids (Cannabidiol, Cannabigerol, Cannabichromene, and Cannabinol) on Their Lymphatic Transport after Enteral Administration in Rats.
Pavel Ryšánek, Petr Jelínek, Hynek Housar, Petr Kozlík, Tomáš Křížek, Mahak Arora

Mol Pharm· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of celastrol on the heart and liver galaninergic system expression in a mouse model of Western-type diet-induced obesity and metabolic dysfunction-associated steatotic liver disease and steatohepatitis.
Nikolina Canová, Jana Šípková, Mahak Arora, Zuzana Pavlíková, Tomáš Kučera

Front Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ivacaftor pharmacokinetics and lymphatic transport after enteral administration in rats.
Jiří Pozniak, Pavel Ryšánek, David Smrčka, Petr Kozlík, Tomáš Křížek, Mahak Arora

Front Pharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological effects of mTORC1/C2 inhibitor in a preclinical model of NASH progression.
Mahak Arora, Zuzana Pavlíková, Tomáš Kučera, Petr Kozlík, Tijana Šopin

Biomed Pharmacother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiated modulation of signaling molecules AMPK and SIRT1 in experimentally drug-induced hepatocyte injury.
Lea Njeka Wojnarova, Nikolina Kutinova Canova, Mahak Arora, Hassan Farghali

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statins and liver.
Jiří Hlušička, Mahak Arora, Radan Brůha, Aleš Žák

Cas Lek Cesk· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR as an eligible molecular target for possible pharmacological treatment of nonalcoholic steatohepatitis.
Mahak Arora, Nikolina Kutinová Canová, Hassan Farghali

Eur J Pharmacol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis